09.08.2018
- US biotech companies Regeneron and bluebird bio are collaborating and applying their respective technology platforms to discover, develop and commercialize novel immune cell...
10.06.2016
- Lonza Houston, part of the Swiss-based life sciences group Lonza, has signed a strategic manufacturing agreement with bluebird bio, a Cambridge, Massachusetts-based clinical-stage...
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
